33 related articles for article (PubMed ID: 38537866)
21. Transjugular intrahepatic portosystemic shunt (TIPS) complications: what diagnostic radiologists should know.
Mamone G; Milazzo M; Di Piazza A; Caruso S; Carollo V; Gentile G; Crinò F; Marrone G; Sparacia G; Maruzzelli L; Miraglia R
Abdom Radiol (NY); 2022 Dec; 47(12):4254-4270. PubMed ID: 36123434
[TBL] [Abstract][Full Text] [Related]
22. [Transjugular intrahepatic portosystemic shunt (TIPS) for the treatment of complications of portal hypertension in patients with liver cirrhosis].
Grønbaek H; Astrup LB; Nielsen DT; Vilstrup H
Ugeskr Laeger; 2003 Jan; 165(5):439-42. PubMed ID: 12599838
[TBL] [Abstract][Full Text] [Related]
23. The role of transjugular intrahepatic portosystemic shunt (TIPS) in the management of portal hypertension.
Colombato L
J Clin Gastroenterol; 2007; 41 Suppl 3():S344-51. PubMed ID: 17975487
[TBL] [Abstract][Full Text] [Related]
24. [Transjugular intrahepatic portosystemic shunt for esophagogastric variceal bleeding in liver cirrhosis: intended population and timing].
Lyu Y; Han GH; Fan DM
Zhonghua Gan Zang Bing Za Zhi; 2017 Jun; 25(6):402-407. PubMed ID: 28763854
[TBL] [Abstract][Full Text] [Related]
25. The smoker's paradox in transjugular intrahepatic portosystemic shunt procedure: A national inpatient sample analysis from 2015 to 2020.
Li R; Sarin S
Clin Res Hepatol Gastroenterol; 2024 May; 48(5):102323. PubMed ID: 38537866
[TBL] [Abstract][Full Text] [Related]
26. Transjugular intrahepatic portosystemic shunt in patients with cirrhosis: Indications and posttransjugular intrahepatic portosystemic shunt complications in 2020.
Horhat A; Bureau C; Thabut D; Rudler M
United European Gastroenterol J; 2021 Mar; 9(2):203-208. PubMed ID: 32819214
[TBL] [Abstract][Full Text] [Related]
27. Direct intrahepatic portocaval shunt (DIPS) or transjugular transcaval intrahepatic portosystemic shunt (TTIPS) to treat complications of portal hypertension: Indications, technique, and outcomes beyond Budd-Chiari syndrome.
Artru F; Moschouri E; Denys A
Clin Res Hepatol Gastroenterol; 2022 Apr; 46(4):101858. PubMed ID: 34999250
[TBL] [Abstract][Full Text] [Related]
28. Expanded polytetrafluoroethylene (ePTFE)-covered stents versus bare stents for transjugular intrahepatic portosystemic shunt in people with liver cirrhosis.
Zhu P; Dong S; Sun P; Belgaumkar AP; Sun Y; Cheng X; Zheng Q; Li T
Cochrane Database Syst Rev; 2023 Aug; 8(8):CD012358. PubMed ID: 37531575
[TBL] [Abstract][Full Text] [Related]
29. Transjugular intrahepatic portosystemic shunt in cirrhosis: An exhaustive critical update.
Rajesh S; George T; Philips CA; Ahamed R; Kumbar S; Mohan N; Mohanan M; Augustine P
World J Gastroenterol; 2020 Oct; 26(37):5561-5596. PubMed ID: 33088154
[TBL] [Abstract][Full Text] [Related]
30. The role of transjugular intrahepatic portosystemic shunt in patients with portal hypertension: Advantages and pitfalls.
Lee HL; Lee SW
Clin Mol Hepatol; 2022 Apr; 28(2):121-134. PubMed ID: 34571587
[TBL] [Abstract][Full Text] [Related]
31.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
32.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
33.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
